載入...
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Treatment with rituximab plus a regimen of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) for patients with diffuse large B-cell lymphoma (DLBCL) has proven efficacy in clinical trials. The present study investigated its application in clinical practice. This single-center, retro...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796369/ https://ncbi.nlm.nih.gov/pubmed/29467881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.7774 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|